However, as defective axoneme acetylation is not observed in CEP41- or ARL13B-deficient cells (Lee et al., 2012; He et al., 2018), we reason that defective axoneme glutamylation is probably the major driver for the development of ciliopathy phenotypes observed in Joubert syndrome patients. This evidence concerns the gene ARL13B and Joubert syndrome.